Trial · NCT02603809
Results by group102
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 102
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline to End of Double-blind Treatment in Sitting Diastolic Blood Pressure at Trough | Placebo | Baseline | 97.5 | Standard Deviation 5.4 | mmHg |
| Change From Baseline to End of Double-blind Treatment in Sitting Diastolic Blood Pressure at Trough | Aprocitentan 5 mg | Baseline | 97.8 | Standard Deviation 5.5 | mmHg |
| Change From Baseline to End of Double-blind Treatment in Sitting Diastolic Blood Pressure at Trough | Aprocitentan 10 mg | Baseline | 97.7 | Standard Deviation 4.3 | mmHg |
| Change From Baseline to End of Double-blind Treatment in Sitting Diastolic Blood Pressure at Trough | Aprocitentan 25 mg | Baseline | 97.8 | Standard Deviation 4.8 | mmHg |
| Change From Baseline to End of Double-blind Treatment in Sitting Diastolic Blood Pressure at Trough | Aprocitentan 50 mg | Baseline | 98.2 | Standard Deviation 5.3 | mmHg |
| Change From Baseline to End of Double-blind Treatment in Sitting Diastolic Blood Pressure at Trough | Lisinopril 20 mg | Baseline | 96.8 | Standard Deviation 4.6 | mmHg |
| Change From Baseline to End of Double-blind Treatment in Sitting Diastolic Blood Pressure at Trough | Placebo | Absolute Change from Baseline to Week 8 | -4.9 | Standard Deviation 11.1 | mmHg |
| Change From Baseline to End of Double-blind Treatment in Sitting Diastolic Blood Pressure at Trough | Aprocitentan 5 mg | Absolute Change from Baseline to Week 8 | -6.3 | Standard Deviation 8.9 | mmHg |
| Change From Baseline to End of Double-blind Treatment in Sitting Diastolic Blood Pressure at Trough | Aprocitentan 10 mg | Absolute Change from Baseline to Week 8 | -9.9 | Standard Deviation 8.7 | mmHg |
| Change From Baseline to End of Double-blind Treatment in Sitting Diastolic Blood Pressure at Trough | Aprocitentan 25 mg | Absolute Change from Baseline to Week 8 | -12.0 | Standard Deviation 8.2 | mmHg |
| Change From Baseline to End of Double-blind Treatment in Sitting Diastolic Blood Pressure at Trough | Aprocitentan 50 mg | Absolute Change from Baseline to Week 8 | -10.0 | Standard Deviation 7.9 | mmHg |
| Change From Baseline to End of Double-blind Treatment in Sitting Diastolic Blood Pressure at Trough | Lisinopril 20 mg | Absolute Change from Baseline to Week 8 | -8.4 | Standard Deviation 9.6 | mmHg |
| Change From Baseline to End of Double-blind Treatment in Sitting Systolic Blood Pressure at Trough | Placebo | Baseline | 149.2 | Standard Deviation 13.1 | mmHg |
| Change From Baseline to End of Double-blind Treatment in Sitting Systolic Blood Pressure at Trough | Aprocitentan 5 mg | Baseline | 149.4 | Standard Deviation 13.9 | mmHg |
| Change From Baseline to End of Double-blind Treatment in Sitting Systolic Blood Pressure at Trough | Aprocitentan 10 mg | Baseline | 149.8 | Standard Deviation 12.7 | mmHg |
| Change From Baseline to End of Double-blind Treatment in Sitting Systolic Blood Pressure at Trough | Aprocitentan 25 mg | Baseline | 151.2 | Standard Deviation 13.7 | mmHg |
| Change From Baseline to End of Double-blind Treatment in Sitting Systolic Blood Pressure at Trough | Aprocitentan 50 mg | Baseline | 148.6 | Standard Deviation 12.8 | mmHg |
| Change From Baseline to End of Double-blind Treatment in Sitting Systolic Blood Pressure at Trough | Lisinopril 20 mg | Baseline | 149.8 | Standard Deviation 14.2 | mmHg |
| Change From Baseline to End of Double-blind Treatment in Sitting Systolic Blood Pressure at Trough | Placebo | Absolute Change from Baseline to Week 8 | -7.7 | Standard Deviation 18.8 | mmHg |
| Change From Baseline to End of Double-blind Treatment in Sitting Systolic Blood Pressure at Trough | Aprocitentan 5 mg | Absolute Change from Baseline to Week 8 | -10.3 | Standard Deviation 15.3 | mmHg |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02603809/results